SCHEMBL27249996

SCHEMBL27249996

Cn1ncc2c1CN(CC(N)=O)CC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 4/20 0.38
▸ WDR77 Q9BQA1 3/20 0.38
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ GRM2 Q14416 1/20 0.33
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ CDK19 Q9BWU1 1/20 0.33
▸ PLK1 P53350 1/20 0.33
▸ CSNK2A1 P68400 1/20 0.33
▸ PLK3 Q9H4B4 1/20 0.33
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ PARP2 Q9UGN5 1/20 0.32
▸ HTR1A P08908 1/20 0.32
▸ DRD2 P14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24577538 0.89 PDCD1 (0.35) PRMT5WDR77GAAMAPTMEN1
SCHEMBL27249907 0.79 PNMT (0.43) PRMT5WDR77PLK1CSNK2A1PLK3
SCHEMBL27249876 0.79 PRMT5 (0.40) PRMT5WDR77PLK1CSNK2A1PLK3
SCHEMBL17377026 0.75 PRMT5 (0.53) PRMT5WDR77KDM4E
SCHEMBL17377104 0.75 PRMT5 (0.53) PRMT5WDR77KDM4E
SCHEMBL27249906 0.74 CHEK1 (0.38) PRMT5WDR77MAPTMEN1KMT2A
SCHEMBL19164213 0.73 PRMT5 (0.51) PRMT5WDR77MEN1KMT2A
SCHEMBL24334184 0.73 NOTUM (0.50) —
SCHEMBL17377185 0.72 PRMT5 (0.52) PRMT5WDR77
SCHEMBL20284596 0.72 PLK1 (0.36) PRMT5WDR77PLK1CSNK2A1PLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 — — US disclosed
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 — — US disclosed
WO-2024077391-A1 THIAZOLO[5,4-D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF UNIVERSITE DE MONTREAL (CA) 2024-04-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS PRMT5 1866/4885WDR77 1260/4885GAA 2372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback